3/4
09:00 am
ormp
Oramed Pharmaceuticals Issues Letter to Shareholders
Medium
Report
Oramed Pharmaceuticals Issues Letter to Shareholders
2/19
02:10 am
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/12
05:27 am
ormp
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch [Yahoo! Finance]
Medium
Report
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch [Yahoo! Finance]
2/11
10:00 am
ormp
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin [Yahoo! Finance]
Medium
Report
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin [Yahoo! Finance]
2/11
09:15 am
ormp
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
High
Report
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
2/6
09:37 pm
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
1/13
11:04 pm
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
1/4
02:03 am
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
12/27
02:14 am
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
12/18
11:06 pm
ormp
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.